0001123292-16-001884.txt : 20160302 0001123292-16-001884.hdr.sgml : 20160302 20160302180928 ACCESSION NUMBER: 0001123292-16-001884 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160302 FILED AS OF DATE: 20160302 DATE AS OF CHANGE: 20160302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc CENTRAL INDEX KEY: 0001395937 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320162505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 460 TOTTEN POND ROAD STREET 2: SUITE 650 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-419-1400 MAIL ADDRESS: STREET 1: 460 TOTTEN POND ROAD STREET 2: SUITE 650 CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sledge George W. Jr. CENTRAL INDEX KEY: 0001601351 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37708 FILM NUMBER: 161478816 MAIL ADDRESS: STREET 1: C/O SYNDAX PHARMACEUTICALS, INC. STREET 2: 400 TOTTEN POND ROAD, SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02451 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2016-03-02 0 0001395937 Syndax Pharmaceuticals Inc SNDX 0001601351 Sledge George W. Jr. C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110 WALTHAM MA 02451 1 0 0 0 Stock Option (right to buy) 6.32 2024-09-15 Common Stock 9321 D Stock Option (right to buy) 6.35 2024-12-18 Common Stock 845 D Stock Option (right to buy) 7.20 2025-08-18 Common Stock 16800 D Twenty-five percent (25%) of the total number of shares underlying the option vested on September 15, 2014, and one forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates. Twenty-five percent (25%) of the total number of shares underlying the option vested on December 18, 2014, and one forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates. Twenty-five percent (25%) of the total number of shares underlying the option vested on August 18, 2015, and one forty-eighth (1/48th) of the total number of shares underlying the option vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates. /s/ Michael A. Metzger, Attorney-in-Fact 2016-03-02 EX-24 2 sledgepoa.htm POWER OF ATTORNEY
Power of Attorney
The undersigned, a member of the Board of Directors of Syndax Pharmaceuticals, Inc., a Delaware corporation (the "Company"), hereby constitutes and appoints Briggs W. Morrison, Michael A. Metzger and John S. Pallies, for so long as each such person is an employee of the Company, and Laura A. Berezin, for so long as she is a partner of a law firm representing the Company, the undersigned's true and lawful attorney-in-fact, each with the power to act alone for the undersigned and in the undersigned's name, place and stead, to:
1.
Prepare, complete and execute Forms 3, 4 and 5 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and other forms and all amendments thereto on the undersigned's behalf as such attorney-in-fact shall in his or her discretion determine to be required or advisable pursuant to Section 16 of the Exchange Act and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned's beneficial ownership of securities of the Company or changes in such beneficial ownership; and
2.
Do all acts necessary in order to file such forms and amendments with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other persons or agencies as the attorney-in-fact shall deem appropriate.
The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with or liability under Section 16 of the Exchange Act or any rules and regulations promulgated thereunder or any successor laws and regulations.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, or 5 with respect to the undersigned's beneficial ownership of securities of the Company or changes in such beneficial ownership, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact.
The undersigned has executed this Power of Attorney as of January 11, 2016.
 
 
 
 
/s/ George W. Sledge
 
 
 
 
George W. Sledge, Jr.